ArticleBreast cancer research and treatment2021

Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry.

Khava I E Ibragimova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.